What should a nurse monitor for in a client prescribed lamotrigine?

Monitoring for rash development in a client prescribed lamotrigine is crucial due to the potential risk of serious skin reactions, including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). These conditions are severe and can be life-threatening, characterized by extensive and painful rashes that can lead to significant health complications.

Due to the risk of such adverse effects, it is important for nurses to assess the patient's skin regularly after starting lamotrigine, particularly during dose increases or when initiating therapy. Early detection of any rash allows for prompt management, which can include discontinuing the medication to prevent progression to more severe conditions. This vigilance is especially important in individuals who may be at higher risk for skin reactions, such as those with a history of SJS or concurrent use of other medications that may also induce rashes.

Weight gain, vision changes, and increased energy are not primary concerns associated with lamotrigine therapy. While any medication can have side effects, the specific and well-documented risk of rash associated with lamotrigine necessitates a focused monitoring strategy centered on skin assessments.